This announcement informs that Shenzhen Haiwang Bioengineering Co., Ltd. experienced abnormal stock price fluctuations, with a cumulative increase exceeding 12% from May 29 to June 1, 2026. The company confirms no undisclosed significant information affecting stock prices and highlights ongoing operational stability. However, it warns investors of potential irrational speculation risks and advises careful decision-making.
Summary generated by AI · Always verify with source document
Shenzhen Haiwang Bioengineering Co., Ltd.
Announcement No.: 2026-042
The company and all members of the board guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.